Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Supplemental
Segments

Unit Economics
Common Size IS
Op Efficiency
Credit Analysis

Sonnet BioTherapeutics Holdings, Inc. (BURG)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsSep-30-22Sep-30-21Sep-30-20Sep-30-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-K10-K10-K10-K
Equity in earnings          
Pre-tax income before non-recurring items  -29.7-25.0-17.4-4.9-5.9-5.4-4.17.9
Non-recurring items    6.8 2.0   
Asset impairment       2.4  
Pre-tax income  -29.7-25.0-24.3-4.9-7.9-7.8-4.17.9
Income taxes  0.00.00.00.0-0.7-0.60.2-0.2
            Tax rate  0.0%0.0%0.0%0.0%8.9%8.3%  
Earnings from continuing ops  -29.7-25.0-65.6-4.9-7.3-7.3-7.8-12.6
Earnings from discontinued ops      0.30.4-1.3-1.9
Net income  -29.7-25.0-65.6-4.9-7.0-6.9-9.1-14.5
            Net margin  -8493.3%-5166.0%  -17.2%-16.7%-21.8%-40.9%
   
Basic EPS  ($6.84)($14.25)($6.96)($0.91)($2.08)($2.88)($3.58)($0.88)
Diluted EPS  ($6.84)($14.25)($6.96)($0.91)($2.08)($2.88)($3.58)($0.88)
   
Shares outstanding (basic)  4.31.89.45.33.52.52.214.2
Shares outstanding (diluted)  4.31.89.45.33.52.52.214.2
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy